Greytown Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,504
Closed -$253K 110
2022
Q1
$253K Buy
3,504
+175
+5% +$12.6K 0.12% 96
2021
Q4
$306K Sell
3,329
-23
-0.7% -$2.75K 0.13% 92
2021
Q3
$425K Hold
3,352
0.19% 77
2021
Q2
$557K Buy
3,352
+438
+15% +$71K 0.27% 61
2021
Q1
$530K Buy
2,914
+329
+13% +$76.3K 0.26% 63
2020
Q4
$517K Buy
2,585
+93
+4% +$18.9K 0.36% 51
2020
Q3
$546K Buy
2,492
+180
+8% +$38.1K 0.45% 34
2020
Q2
$441K Sell
2,312
-412
-15% -$72.2K 0.41% 38
2020
Q1
$422K Buy
2,724
+4
+0.1% +$465 0.42% 49
2019
Q4
$228K Buy
+2,720
New +$207K 0.16% 64

Other funds holding TDOC

Greytown Advisors's TDOC Position: Q2 2022 in Review

Greytown Advisors sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,504 shares — an estimated $253K sold.

Greytown Advisors first reported a position in TDOC in Q4 2019 and held it in 10 quarters. The position peaked at $557K in Q2 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Greytown Advisors reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Greytown Advisors sold 3,504 Teladoc Health shares in Q2 2022, an estimated $253K.
  • Greytown Advisors first reported a position in Teladoc Health in Q4 2019 and held it in 10 quarters.
  • Greytown Advisors's Teladoc Health position peaked at $557K in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Greytown Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.